Navigation Links
Interim Data Announced for BIBF 1120 as Compared to bevacizumab in Combination Chemotherapy in Metastatic Colorectal Cancer
Date:9/27/2011

STOCKHOLM, Sept. 27, 2011 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced interim results from an exploratory clinical trial evaluating its investigational compound BIBF 1120 in patients with metastatic colorectal cancer (mCRC).  In this Phase I/II study of 126 patients comparing BIBF 1120 as first-line treatment to bevacizumab, both in combination with mFOLFOX6 (6th modified regimen of folinic acid [leucovorin], fluorouracil, and oxaliplatin), the progression-free survival (PFS) rate at 9 months was 63 percent (95% CI: 50%-75%) in the BIBF 1120 arm and 69% (95% CI: 53%-86%) in the bevacizumab arm.(1)  The median PFS was numerically similar between both groups at 10.6 months ([95% CI: 9.4-12.3] for the BIBF 1120 arm and [95% CI: 9.1-NA] for the bevacizumab arm).(2)

The study, presented at the Presidential Session of the 2011 European Multidisciplinary Cancer Congress in Stockholm, Sweden, also showed that the objective response rate (ORR), a measure of tumor shrinkage, was 61 percent in the BIBF 1120 arm and 54 percent in the bevacizumab arm.(1)

While both treatment arms showed similar safety profiles, a lower incidence of serious adverse events was seen in patients taking BIBF 1120 compared to those taking bevacizumab (34% vs. 54%).(2)  Adverse events (grade 3 or higher) experienced by at least 10 percent of patients in the BIBF 1120 and bevacizumab arms included neutropenia (32% vs. 24%), diarrhea (15% vs. 12%), neurotoxicity (14% vs. 10%), paresthesia (13% vs. 12%) and asthenia (11% vs. 10%).(1)  Patients receiving BIBF 1120 experienced a lower frequency of serious gastrointestinal adverse events than those receiving bevacizumab (12% vs. 29%).(2)

The study is ongoing in order to collect overall survival (OS) data. Phase III trials with larger patient populations will be considered to confirm these results and to further investigate the potential of BIBF 1120 in mCRC.

"The study results
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
3. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
4. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
5. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
6. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
7. Grantees of the Avon Foundation Breast Cancer Prevention Research Initiative Gather in Houston to Report Interim Findings
8. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
9. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
10. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
11. NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... DUBLIN , Apr. 14, 2015 Research and ... addition of the "US Proton Therapy Outlook - ... According to the US Proton Therapy Outlook: Market Opportunities ... will be home to almost 29 such centers ... current figure. Consequently, the market will breach the Billion ...
(Date:4/20/2015)... , April 20, 2015  In its latest ... markets, the FTC announced that Cardinal Health, Inc. ... monopolized 25 local markets for the sale and ... clinics to pay inflated prices for these drugs. ... $26.8 million of ill-gotten gains and represents the ...
(Date:4/20/2015)... April 20, 2015  Ameritox,s Ingenuity Health, a leading ... presented clinical research at the National Council of Behavioral ... , showing that nearly 25 percent of the samples ... not contain the prescribed antipsychotic medication. ... ...
Breaking Medicine Technology:United States Proton Therapy Outlook to 2018 - Market Opportunities for the $1.19 Billion Market Featuring IBA, Hitachi, Mevion Medical Systems & Varian 2United States Proton Therapy Outlook to 2018 - Market Opportunities for the $1.19 Billion Market Featuring IBA, Hitachi, Mevion Medical Systems & Varian 3Cardinal Health Agrees to Pay $26.8 Million to Settle Charges It Monopolized 25 Markets for the Sale of Radiopharmaceuticals to Hospitals and Clinics, says FTC 2Cardinal Health Agrees to Pay $26.8 Million to Settle Charges It Monopolized 25 Markets for the Sale of Radiopharmaceuticals to Hospitals and Clinics, says FTC 3Cardinal Health Agrees to Pay $26.8 Million to Settle Charges It Monopolized 25 Markets for the Sale of Radiopharmaceuticals to Hospitals and Clinics, says FTC 4Cardinal Health Agrees to Pay $26.8 Million to Settle Charges It Monopolized 25 Markets for the Sale of Radiopharmaceuticals to Hospitals and Clinics, says FTC 5Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 2Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 3
... Thoratec Corporation (Nasdaq: THOR ), a ... save, support and restore failing hearts, said today that ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... of International Technidyne Corporation (ITC) to Danaher Corporation ( ...
... Legitimate Medical Equipment Providers Are Victimized by Administrative Backlogs ... , ... recent study by the Government Accountability Office (GAO) confirms that the ... be a problem despite the government,s efforts to implement reforms.  The ...
Cached Medicine Technology:Thoratec Announces Early Termination of HSR Waiting Period for the Sale of ITC to Danaher Corporation 2GAO Confirms Payment Delays to Medical Equipment Providers; Questions Arise as to Whether Medicare Can Implement Reforms 2GAO Confirms Payment Delays to Medical Equipment Providers; Questions Arise as to Whether Medicare Can Implement Reforms 3GAO Confirms Payment Delays to Medical Equipment Providers; Questions Arise as to Whether Medicare Can Implement Reforms 4
(Date:4/21/2015)... April 21, 2015 “The warm summer season ... every mother want to look younger than her age? ... first line of defense. Signs of premature aging ... evidence of too much time spent in the sun without ... to cover up. The dangers of UV rays can ...
(Date:4/20/2015)... Is it possible to create measures of ... the local needs of the providers, payers and patients who ... over the past year by the Hutchinson Institute for Cancer ... Center in Seattle, Washington. , In a new commentary ... Journal of Managed Care, HICOR Director Scott Ramsey, MD, ...
(Date:4/20/2015)... (PRWEB) April 20, 2015 The partners of ... the community to Bella Diosa Laser Med Spa with a ... a spa party on from 12–7 p.m. on April 24 ... will include drinks and refreshments. Participants will also get the ... receive a free gift with any purchase, as well as ...
(Date:4/20/2015)... A recent cross-sectional survey ... list the top 10 most beneficial therapies for fibromyalgia, no ... most harmful therapies, only approved drugs were named. , ... help, their effect is only felt as long as the ... recent interview. , “On the other hand, aerobic exercise and ...
(Date:4/20/2015)... Salt Lake City, Utah (PRWEB) April 20, 2015 ... The End of Employer-Provided Health Insurance: Why It’s Good ... Apr. 30, 2015. , Paul Zane Pilzer and Rick ... End of Employer-Provided Health Insurance: Why It’s Good for ... solution to our nation’s employer health insurance woes - ...
Breaking Medicine News(10 mins):Health News:Sun’s the Word this Mother’s Day Say’s SunGrubbies.com, a Leading Retailer of Sun Protection Products 2Health News:Creating Value Metrics in Cancer Care From the Bottom Up 2Health News:Creating Value Metrics in Cancer Care From the Bottom Up 3Health News:Bella Diosa Says Hello to Yonkers Community with Spa Party 2Health News:Medical Doctor in Huntsville Reveals That Aerobic Exercise Offers Best Results in Fibromyalgia Treatment 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 3
... The ... home care, has announced that a state chapter has been formed in Iowa. , ... (Vocus) October 16, 2009 -- The National Private ... announced that a state chapter has been formed in Iowa. , , , , ,"Because ...
... ... Polycom help customers transform their business, improve collaboration, enhance productivity and reduce costs. ... ... ), a leading worldwide managed service provider of videoconferencing and telepresence solutions, today ...
... for sugary drinks haven,t slowed obesity epidemic, study finds ... and levies on soft drinks are slowing consumption, but not ... researchers say. , In an analysis of 16 years of ... drink taxation affected body mass index, researchers found that taxation ...
... 16 A new nationwide survey released today reveals ... the age of 18 have spoken to their child,s ... nearly 90 percent say they want to know more. ... of Minnesota (Children,s), assessed parents, attitudes about various approaches ...
... Snackfood US announced today that Kyle Busch, driver of the No. ... go pink this weekend during the NASCAR Banking 500 only from ... Komen for the Cure®. Busch plans to don a special ... all pink M&M,S car during the Saturday night race to help ...
... Deborah Friberg, Chief Operating Officer and Executive Vice President ... been named the recipient of the first annual ... by the Association for Professionals in Infection Control and ... team member who has demonstrated significant support for infection ...
Cached Medicine News:Health News:National Private Duty Association Announces Formation of an Iowa Chapter 2Health News:BCS Global Completes Polycom Telepresence VNOC (Video Network Operations Center) Provider Program 2Health News:BCS Global Completes Polycom Telepresence VNOC (Video Network Operations Center) Provider Program 3Health News:Soda Taxes Not Making a Dent in U.S. Waistlines 2Health News:Survey Reveals Parents Are Eager to Learn about Alternative Medicine Options but Information is Lacking 2Health News:Survey Reveals Parents Are Eager to Learn about Alternative Medicine Options but Information is Lacking 3Health News:Mars Lends Sweet Support in Fight Against Breast Cancer Through Its M&M's(R) And Dove(R) Chocolate Brands, as Well as Its Celebrated Race Team 2Health News:Mars Lends Sweet Support in Fight Against Breast Cancer Through Its M&M's(R) And Dove(R) Chocolate Brands, as Well as Its Celebrated Race Team 3Health News:APIC Announces Winner of First Healthcare Administrator Award 2Health News:APIC Announces Winner of First Healthcare Administrator Award 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: